Once exclusively a treatment for diabetes, GLP-1 drugs such as Zepbound and Wegovy, which suppress appetite and slow digestion, have become a mainstream weight-loss tool
Exilis is not meant to make you lose weight
Semaglutide causes gastrointestinal side effects in a significant percentage of users
Dropout rates in the placebo group were significantly higher than expected, which the authors partly attributed to semaglutides commercial availability during the trial period, potentially drawing less satisfied placebo participants to seek treatment elsewhere
Our Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R pathways that may help provide context for how your physiology responds to GLP-1 and GIP receptor activation
They're fragile molecules heat, light, and rough handling destroy them so proper storage matters